APA (7th ed.) Citation

EW, R., WH, S., PA, C., C, C., SL, G., RA, R., . . . AW, S. (2010). Natalizumab plus interferon beta-1a reduces lesion formation in relapsing multiple sclerosis. Journal of the neurological sciences, 292(1-2), 28. https://doi.org/10.1016/j.jns.2010.02.012

Chicago Style (17th ed.) Citation

EW, Radue, et al. "Natalizumab Plus Interferon Beta-1a Reduces Lesion Formation in Relapsing Multiple Sclerosis." Journal of the Neurological Sciences 292, no. 1-2 (2010): 28. https://doi.org/10.1016/j.jns.2010.02.012.

MLA (9th ed.) Citation

EW, Radue, et al. "Natalizumab Plus Interferon Beta-1a Reduces Lesion Formation in Relapsing Multiple Sclerosis." Journal of the Neurological Sciences, vol. 292, no. 1-2, 2010, p. 28, https://doi.org/10.1016/j.jns.2010.02.012.